Nicholas Investment Partners’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,148
Closed -$5.97K 215
2023
Q3
$5.97K Hold
27,148
﹤0.01% 184
2023
Q2
$6.79K Hold
27,148
﹤0.01% 190
2023
Q1
$6.79K Hold
27,148
﹤0.01% 187
2022
Q4
$10.9K Hold
27,148
﹤0.01% 177
2022
Q3
$12K Hold
27,148
﹤0.01% 175
2022
Q2
$21K Hold
27,148
﹤0.01% 173
2022
Q1
$55K Hold
27,148
﹤0.01% 191
2021
Q4
$91K Hold
27,148
0.01% 194
2021
Q3
$94K Buy
+27,148
New +$83.7K 0.01% 188

Other funds holding SLGCW

Nicholas Investment Partners's SLGCW Position: Q4 2023 in Review

Nicholas Investment Partners sold out of SomaLogic, Inc. Warrant (SLGCW) in Q4 2023, closing a stake of 27,148 shares — an estimated $5.97K sold.

Nicholas Investment Partners first reported a position in SLGCW in Q3 2021 and held it in 9 quarters. The position peaked at $94K in Q3 2021. 25 funds tracked by Wall St. Rank hold SLGCW as of Q4 2023.

  • Nicholas Investment Partners reported no remaining SomaLogic, Inc. Warrant position as of Q4 2023 after selling out during the quarter.
  • Nicholas Investment Partners sold 27,148 SomaLogic, Inc. Warrant shares in Q4 2023, an estimated $5.97K.
  • Nicholas Investment Partners first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 9 quarters.
  • Nicholas Investment Partners's SomaLogic, Inc. Warrant position peaked at $94K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q4 2023.

Based on Nicholas Investment Partners's 13F filing for Q4 2023, filed 8 Feb 2024.